Easing the Disease Burden of Patients with Atopic Dermatitis
5 episodes - English - Latest episode: over 2 years ago -Atopic dermatitis (AD) is a skin condition with substantial direct and indirect effects on patients. Guidelines for the management of AD were published in 2014, and while many of the tenets of basic AD skin care are well established, patients with AD are still not achieving optimal disease control in real-world practice. In this activity, Dr. Jonathan Silverberg reviews the burden of AD and the unmet needs within AD management today. Components of basic skin care from the 2014 guidelines are reviewed, followed by the most recent data supporting approved therapies and newly emerging oral and to
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Emerging Therapies: Phase 3 Efficacy & Safety Data
November 01, 2021 15:16 - 16 minutes - 15.3 MBJAK-STAT inhibitors: oral and topical JAK-STAT inhibitors vs dupilumab IL-13 antagonists IL-31 antagonists
AD Therapies Approved After 2014 AAD Guidelines
November 01, 2021 15:16 - 12 minutes - 11.1 MBMechanism of action, indication, efficacy, and safety Dupilumab Crisaborole
Adherence to Evidence-Based Guidelines
November 01, 2021 15:15 - 6 minutes - 5.6 MB2014 AAD Guidelines Recommendations for topical therapies Recommendations for phototherapy
Components of Basic AD Care
November 01, 2021 15:15 - 4 minutes - 4.08 MBRole of bathing and moisturizers Role of topical corticosteroids
Unmet Needs in AD Care
November 01, 2021 15:15 - 4 minutes - 4.44 MBDirect and indirect effects of AD Discordance in disease burden between providers and patients Rates of inadequate disease control